VANGUARD GROUP INC 13D and 13G filings for Cytosorbents Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-31 6:49 pm Purchase |
2024-12-31 | 13G | Cytosorbents Corporation CTSO |
VANGUARD GROUP INC | 3,899,102 7.130% |
1,942,274 (+99.26%) |
Filing |
| 2023-02-09 11:16 am Sale |
2022-12-30 | 13G | Cytosorbents Corporation CTSO |
VANGUARD GROUP INC | 1,956,828 4.480% |
-252,337 (-11.42%) |
Filing |
| 2022-02-09 3:43 pm Sale |
2021-12-31 | 13G | Cytosorbents Corporation CTSO |
VANGUARD GROUP INC | 2,209,165 5.080% |
-12,441 (-0.56%) |
Filing |
| 2021-02-10 10:46 am Purchase |
2020-12-31 | 13G | Cytosorbents Corporation CTSO |
VANGUARD GROUP INC | 2,221,606 5.150% |
2,221,606 (New Position) |
Filing |